- CMTA’s Strategic Investment Advances Research for CMT1A and CMT1B
The Charcot-Marie-Tooth Association (CMTA) continues its mission to accelerate research that impacts the lives of those living with Charcot-Marie-Tooth disease (CMT). Building on previous successes, CMTA announced earlier this year a strategic $450,000 investment in ...
Read more ... - CMTA Supports the Accelerating Kids’ Access to Care Act (H.R.4758 / S.2372)
THE CHARCOT-MARIE-TOOTH ASSOCIATION SUPPORTS THE ACCELERATING KIDS’ ACCESS TO CARE ACT (H.R.4758 / S.2372)
The Accelerating Kids’ Access to Care Act (H.R.4758 / S.2372) is a bipartisan bill that aims to simplify the Medicaid enrollment process, ...
Read more ... - Mindset Strategies for Kids and Teens with CMT
Growing up with a disability presents layers of challenges at school, in social settings, and within our children and teens’ inner lives. Education and disability expert Sarah Kesty will show you and your child or ...
Read more ... - Exploring New Therapeutic Pathways for CMT1B: UPR Activation
Researchers at the Ospedale San Raffaele (OSR) Scientific Institute in Milan, Italy, supported by the Charcot-Marie-Tooth Association (CMTA) and its Strategy To Accelerate Research (STAR), have made encouraging progress in developing a potential treatment for ...
Read more ... - Advancing the Understanding of CMT2A and CMT2F: A Call to Beat CMT
The Charcot-Marie-Tooth Association (CMTA), through its Strategy To Accelerate Research (STAR) initiative, is proud to support groundbreaking research that seeks to deepen our understanding of CMT2A and CMT2F, two axonal forms of Charcot-Marie-Tooth disease (CMT). ...
Read more ...